- €135.38m
- €658.52m
- €1.88bn
- 52
- 91
- 40
- 68
Annual income statement for KME SpA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2019 December 31st | R2020 December 31st | C2021 December 31st | R2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 12.3 | 13 | 0 | 1,465 | 1,881 |
| Cost of Revenue | |||||
| Gross Profit | — | — | — | 354 | 563 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 10.3 | 7.37 | 6.32 | 1,465 | 1,851 |
| Operating Profit | 1.99 | 5.58 | -6.32 | 0.12 | 29.3 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -2.98 | 1.32 | 63.9 | 15.6 | -46.5 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -1.87 | 1.27 | 65.3 | 35.5 | -46.5 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | -1.87 | 1.27 | 65.3 | 35.5 | -40.3 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -1.87 | 1.27 | 65.3 | 35.5 | -40.3 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.004 | 0.003 | 0.164 | 0.11 | -0.154 |
| Dividends per Share |